Insights from 2023 EHA® Annual Meeting

 

Insights from 2023 EHA® Annual Meeting
A

EHA® 2023 Insights: "Epcoritamab With Rituximab + Lenalidomide in Patients With High-Risk R/R FL"

By Insights from 2023 EHA® Annual Meeting FEATURING Anna Sureda
By Insights from 2023 EHA® Annual Meeting FEATURING Anna Sureda
33 views
July 17, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
Lymphoma
10:42
Insights from 2023 EHA® Annual Meeting

EHA® 2023 Insights: "Epcoritamab With Rituximab + Lenalidomide …

Feat. A. Sureda
02:18
Insights from 2023 EHA® Annual Meeting

2023 EHA® Insights: "Matching-Adjusted Indirect Comparison of Z…

Feat. C. Thieblemont